Brendan McAtamney

UDG Healthcare Plc engages in the supply and distribution of pharmaceutical and medical products. It operates through the following segments: Ashfield, Sharp, and Aquilant. The Ashfield segment provides commercialization services for the pharmaceutical and healthcare industry. The Sharp segment offers contract packaging and clinical trial packaging services. The Aquilant segment involves. outsourced sales, marketing, distribution, and engineering services to the medical and scientific sectors. The company was founded in 1948 and is headquartered in Dublin, Ireland.

Scapa Group Plc is a holding company, which engages in the manufacture and marketing of bonding products and adhesive components for applications in the healthcare and industrial markets. It operates through the Industrial and Healthcare segments. The company was founded in 1927 and is headquartered in Ashton-under-Lyne, The United Kingdom.

Aquilant Scientific (UK) Ltd. conducts research on chromatography. The company was founded in April 25, 1991 and is headquartered in Ashby De La Zouch, the United kingdom.

Part of UDG Healthcare Ltd. (Dublin), UDG Healthcare (UK) Holdings Ltd. functions as an investment holding British company. The private company is based in Ashby De La Zouch, UK. UDG Healthcare (UK) Holdings was founded in 1997.

Founded in 2016, UDG Healthcare UK (Holdco) Ltd. is a private company that functions as an investment holding company. Part of UDG Healthcare Ltd. (Dublin), the company is based in Ashby de la Zouch, UK.

Panacea Technologies Inc is a leading provider of solutions optimizing life sciences operations. The private company is based in Montgomeryville, PA, and has subsidiaries in Belgium, Ireland, and the United States. The company offers a full suite of automation and validation services, including process control products and data-driven software for everyone. Panacea Technologies has a track record of successful projects in the pharmaceutical and biotechnology industries, and it has extended its project services and openbio offerings to the gene therapy and cdmo sectors. The company has a large team of engineers ready to support clients across the globe. Panacea Technologies was founded in 1996 by Abhijit Jog, and Pieter Krynauw has been the CEO of the company since 2023.